Related Experiment Videos
Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man?
British Journal of Clinical Pharmacology
|July 1, 1986
Summary
Beta-blockers like propranolol, sotalol, and timolol effectively reduced exercise tachycardia. Non-cardioselective beta-blockers also blocked exercise-induced hand tremor, unlike atenolol or placebo.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Neuroscience
Background:
- Beta-adrenergic receptor antagonists (beta-blockers) are widely used for cardiovascular conditions.
- Understanding the selectivity of beta-blocker action is crucial for optimizing therapeutic effects and minimizing side effects.
- Exercise provides a physiological stressor that can reveal differences in drug action.
Purpose of the Study:
- To investigate the effects of specific beta-blockers on exercise-induced tachycardia and hand tremor.
- To assess the selectivity of beta-adrenoceptor blockade in healthy volunteers.
- To determine if hand tremor blockade can serve as a marker for beta-blocker selectivity.
Main Methods:
- Four healthy volunteers received intravenous doses of propranolol, sotalol, timolol, atenolol, and a placebo.
- Participants underwent exercise protocols to induce tachycardia and hand tremor.
- Heart rate and hand tremor severity were measured and compared across drug conditions.
Main Results:
- All tested beta-blockers significantly reduced exercise-induced tachycardia.
- Non-selective beta-blockers (propranolol, sotalol, timolol) effectively blocked exercise-induced hand tremor.
- Atenolol (a cardioselective beta-blocker) and placebo did not significantly reduce hand tremor.
Conclusions:
- Non-cardioselective beta-blockers exhibit a broader range of effects beyond heart rate reduction.
- The blockade of exercise-induced hand tremor by non-cardioselective agents suggests a role for beta-adrenoceptors in tremor regulation.
- Assessing the inhibition of exercise-induced hand tremor may offer a novel method for evaluating beta-adrenoceptor blockade selectivity in humans.